![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
Selective cyclooxygenase-2 (COX-2) inhibitors now represent a new generation of anti-inflammatory drugs with reduced gastrointestinal side effects compared to current non-steroidal anti-inflammatory drugs (NSAIDs). The present patent claims selective COX-2 inhibitors based on the pyridazinone template in the tricyclic class, which was derived from DuP-697.